Literature DB >> 20061403

The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses.

Sven Kuenzel1, Andreas Till, Michael Winkler, Robert Häsler, Simone Lipinski, Sascha Jung, Joachim Grötzinger, Helmut Fickenscher, Stefan Schreiber, Philip Rosenstiel.   

Abstract

Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring their pivotal role in host defense and immunity. This report describes the genomic organization and regulation of the human NLR family member NLRC5 and aspects of cellular function of the encoded protein. We have analyzed the tissue-specific expression of NLRC5 and have characterized regulatory elements in the NLRC5 promoter region that are responsive to IFN-gamma. We show that NLRC5 is upregulated in human fibroblasts postinfection with CMV and demonstrate the role of a JAK/STAT-mediated autocrine signaling loop involving IFN-gamma. We demonstrate that overexpression and enforced oligomerization of NLRC5 protein results in activation of the IFN-responsive regulatory promoter elements IFN-gamma activation sequence and IFN-specific response element and upregulation of antiviral target genes (e.g., IFN-alpha, OAS1, and PRKRIR). Finally, we demonstrate the effect of small interfering RNA-mediated knockdown of NLRC5 on a target gene level in the context of viral infection. We conclude that NLRC5 may represent a molecular switch of IFN-gamma activation sequence/IFN-specific response element signaling pathways contributing to antiviral defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061403     DOI: 10.4049/jimmunol.0900557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  86 in total

1.  A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses.

Authors:  Andreas Neerincx; Katja Lautz; Maureen Menning; Elisabeth Kremmer; Paola Zigrino; Marianna Hösel; Hildegard Büning; Robert Schwarzenbacher; Thomas A Kufer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 2.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

3.  NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.

Authors:  Yikun Yao; Yalong Wang; Fuxiang Chen; Yin Huang; Shu Zhu; Qibin Leng; Hongyan Wang; Yufang Shi; Youcun Qian
Journal:  Cell Res       Date:  2012-04-10       Impact factor: 25.617

4.  Cutting edge: NLRC5-dependent activation of the inflammasome.

Authors:  Beckley K Davis; Reid A Roberts; Max T Huang; Stephen B Willingham; Brian J Conti; W June Brickey; Brianne R Barker; Mildred Kwan; Debra J Taxman; Mary-Ann Accavitti-Loper; Joseph A Duncan; Jenny P-Y Ting
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 5.  Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines.

Authors:  Brianne R Barker; Debra J Taxman; Jenny P-Y Ting
Journal:  Curr Opin Immunol       Date:  2011-08-10       Impact factor: 7.486

6.  Engineering macrophages to control the inflammatory response and angiogenesis.

Authors:  K V Eaton; H L Yang; C M Giachelli; M Scatena
Journal:  Exp Cell Res       Date:  2015-11-21       Impact factor: 3.905

7.  NLRC5: a NOD-like receptor protein with many faces in immune regulation.

Authors:  Yue Zhao; Feng Shao
Journal:  Cell Res       Date:  2012-05-22       Impact factor: 25.617

Review 8.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

Review 9.  Inflammasomes and its importance in viral infections.

Authors:  Gaurav Shrivastava; Moisés León-Juárez; Julio García-Cordero; David Eduardo Meza-Sánchez; Leticia Cedillo-Barrón
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 10.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.